ton rabelink

74 posts

ton rabelink banner
ton rabelink

ton rabelink

@RabelinkT

Professor of Medicine, Leiden University Medical Center

Katılım Nisan 2014
137 Takip Edilen148 Takipçiler
ton rabelink retweetledi
reNEW
reNEW@reNEW_Global·
World-first breakthrough! reNEW Melbourne researchers at @MCRI have created lab-grown blood stem cells resembling those in the human body. This could pave the way towards personalised treatments for blood diseases such as leukemia & bone marrow failure. 🔗 nature.com/articles/s4158… Read more: renew.science/stories/renew-…
English
1
8
25
2.6K
ton rabelink
ton rabelink@RabelinkT·
Up to 60% of the human adult body is water. However, in tissue this water is bound and associated for a big part to the polysaccharide Hyaluronan. This gel-like component of tissue is critical to tissue repair development rdcu.be/dR9WX @NatRevNeph @reNEW_Global
ton rabelink tweet media
English
3
2
16
740
ton rabelink
ton rabelink@RabelinkT·
@twitt_login Up to 60% of the human adult body is water. However, in tissue this water is bound and associated for a big part to the polysaccharide Hyaluronan. This gel-like component of the tissue is critical to tissue repair and organ development.…rdcu.be/dR9WX
ton rabelink tweet media
English
0
0
1
13
ton rabelink retweetledi
nature
nature@Nature·
Nature research paper: Bridge RNAs direct programmable recombination of target and donor DNA go.nature.com/3VDSJb3
English
1
39
105
24.1K
ton rabelink retweetledi
ERA - European Renal Association
COL4A3 and COL4A4 pathogenic variants in the normal population: redefining Alport syndrome? By Judy Savige ✏️@drvt87 #ERA24 #SoMe team 💥Time to change from Alport syndrome to Alport spectrum!! ⚡️ XL- kidney failure in males and 20% of females by the age of 60 ⚡️ AR-kidney failure in males and females ⚡️ Digenic Alport syndrome ⚡️ AD-haematuria; kidney failure is uncommon
ERA - European Renal Association tweet media
English
1
28
71
6.9K
ton rabelink retweetledi
NEJM
NEJM@NEJM·
Presented at #ERA24: In this phase 2 randomized trial, the CD38 monoclonal antibody felzartamab showed acceptable safety and promising efficacy among patients with chronic antibody-mediated kidney-transplant rejection. Read the full trial results: nej.md/4dHQhsa
NEJM tweet media
English
1
47
104
35K
ton rabelink retweetledi
nature
nature@Nature·
Researchers have mapped a tiny piece of the human brain in astonishing detail go.nature.com/4anVZN5
English
4
59
234
42.4K
ton rabelink
ton rabelink@RabelinkT·
Using spatial metabolic flux we identified the conditions to preserve discarded human donor kidney’s for at least 4 days ex vivo. Such an approach also holds the potential for resuscitation and could increase the window for organ allocation. rdcu.be/dHL6W
ton rabelink tweet media
English
5
18
62
6.7K
ton rabelink retweetledi
Int Society of Nephrology
Int Society of Nephrology@ISNkidneycare·
International consensus statement published in @NatRevNeph calls for urgent action to address CKD on the global public health agenda. Read “Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus” ➡️ doi.org/10.1038/s41581…
Int Society of Nephrology tweet mediaInt Society of Nephrology tweet mediaInt Society of Nephrology tweet mediaInt Society of Nephrology tweet media
English
2
37
61
10.2K
ton rabelink retweetledi
ESC & iPSC News
ESC & iPSC News@ESC_iPSC_News·
reNEW (@reNEW_Global) scientists from @LUMC_Leiden developed and validated a platform for generating GMP-compliant hiPSC lines. 🧫 The platform entails the methodology for donor recruitment, donor material procurement, hiPSCs manufacture, and more. bit.ly/4adfOqw
ESC & iPSC News tweet media
English
0
4
11
1.3K
ton rabelink retweetledi
reNEW
reNEW@reNEW_Global·
reNEW researchers in the @LUMC_Leiden have established an in-house platform to produce #GMP-compliant #hiPSCs. The platform is a key milestone as it allows the production of hiPSC derived cell therapy products developed in reNEW for clinical purposes. sciencedirect.com/science/articl…
reNEW tweet media
English
0
2
22
1.1K